Article
Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Antiviral research - 1 Aug 2011
Shiota Tomoyuki, Lixin Wang, Takayama-Ito Mutsuyo, Iizuka Itoe, Ogata Momoko, Tsuji Masanori, Nishimura Hidekazu, Taniguchi Shuichi, Morikawa Shigeru, Kurane Ichiro, Mizuguchi Masashi, Saijo Masayuki
Abstract excerpt
Antiviral-resistant herpesvirus infection has become a great concern for immunocompromised patients. Herpes simplex virus type 1 (HSV-1) infections are treated with viral thymidine kinase (vTK)-associated drugs such as acyclovir (ACV), and most ACV-resistance (ACV(r)) is due to mutations in the vTK. The standard drug sensitivity test is usually carried out by the plaque reduction assay-based method, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
